Skip to content
★ Sign in to follow
Insider activity · 24 months0 buys1 saleCumulative net flow
Total declarations
26
Company
1
▲ Purchases (0 ops.)
—
▼ Sales (5 ops.)
€1.3M

Latest filing published 17 Jul 2026 for Catalyst Pharmaceuticals, INC., €1.5M.

Filing timeline

BuySale
Preethi Sundaram

Insider track record

Disclosed buys
0
Disclosed sells
5

Not enough buy signals with a settled T+90 horizon to measure a track record yet.

Signal history

Preethi Sundaram: trading record in brief

This profile gathers the share dealings of Preethi Sundaram in Catalyst Pharmaceuticals, Inc. The record holds 26 filings, for trades running from 15 September 2022 to 15 July 2026.

On the market, this insider has only sold: 5 sales, €1.3M in total. Outside the open market, there are 9 share grants and 11 option exercises.

On 17 July 2026 came the latest disclosure, a transaction for €1.5M in Catalyst Pharmaceuticals, Inc. Typically, a trade is published a median of 2 days after it takes place. Section 16 rules allow two business days to file each Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.

Companies and markets linked to Preethi Sundaram

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations15 total

15 of 15 declarations